iifl-logo

News Overview

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Download App
image

Shilpa Medicare Limited has informed the Exchange regarding Intimation U/R 30 OF SEBI(LODR).Shilpa s Pemetrexed Injection 1000 mg/100 ml, 500 mg/50 ml & 100 mg/10 ml, Ready to Use formulation is approved by European Authorities

image

Agro Tech Foods Limited has informed the Exchange about Presentation

image

C.E. Info Systems Limited has informed the Exchange about Schedule of meet

image

Gujarat Alkalies and Chemicals Limited has informed the Exchange about Loss of Share Certificates. Pursuant to Regulation 39(3) of the SEBI (LODR) REGULATIONS, 2015, please find attached details of shareholder(s) from whom application(s) is/are received on 19.01.2022 for issue of duplicate share certificates in lieu of lost / misplaced. Our R & T Agent, Link Intime India Pvt. Ltd., Vadodara is verifying the documents submitted by the aforesaid applicant(s). If the applications/documents/information submitted by the above applicant(s) is/are not as per the guidelines, our R&T Agent will send necessary communications requesting them to submit the same. Upon receipt of all information / documents, the proposal for issue of duplicate share certificate/s shall be considered by the Company and duplicate share certificate/s will be issued within statutory time limit from the date of receipt of relevant information/documents. This is for your kind information please.

image

Just Dial Limited has informed the Exchange about Copy of Newspaper Publication

image

AstraZeneca Pharma India Limited has informed the Exchange regarding Certificate dated January 3, 2022 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. .

image

Polycab India Limited has informed the Exchange regarding Un-audited Interim Condensed (Standalone and Consolidated) Financial Statements for the quarter and nine months ended 31st December 2021.

image

Bigbloc Construction Limited has informed the Exchange about Schedule of meet

image

Motilal Oswal Financial Services Limited has informed the Exchange about Earnings concall

image

Refex Industries Limited has informed the Exchange about Credit Rating

Download App
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.